Clinical trials sponsored by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
7
Recruiting trials
12
Conditions studied
Phase breakdown
Phase 1 3Phase 2 4Phase 3 1Phase 4 1
Conditions studied
Recruiting trials led by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer
- A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity
- A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
- A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus
- A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treating Chinese Children With Severe Plaque Psoriasis
- Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
- D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure
Common questions
How many trials is Chia Tai Tianqing Pharmaceutical Group Co., Ltd. recruiting for?
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is the lead sponsor of 7 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.